mTORC1 Links Pathology in Experimental Models of Still’s Disease and Macrophage Activation Syndrome

Single-cell RNA sequencing in a murine model of Still’s disease showed preferential activation of mechanistic target of rapamycin complex 1 (mTORC1) in monocytes; both mTOR inhibition and monocyte depletion attenuated disease severity.